143 related articles for article (PubMed ID: 21123455)
1. IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer.
Lo CW; Chen MW; Hsiao M; Wang S; Chen CA; Hsiao SM; Chang JS; Lai TC; Rose-John S; Kuo ML; Wei LH
Cancer Res; 2011 Jan; 71(2):424-34. PubMed ID: 21123455
[TBL] [Abstract][Full Text] [Related]
2. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies.
Ataie-Kachoie P; Morris DL; Pourgholami MH
PLoS One; 2013; 8(4):e60817. PubMed ID: 23593315
[TBL] [Abstract][Full Text] [Related]
3. An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.
El-Husseini ZW; Khalenkow D; Lan A; van der Molen T; Brightling C; Papi A; Rabe KF; Siddiqui S; Singh D; Kraft M; Beghe B; van den Berge M; van Gosliga D; Nawijn MC; Rose-John S; Koppelman GH; Gosens R
Respir Res; 2023 Dec; 24(1):308. PubMed ID: 38062491
[TBL] [Abstract][Full Text] [Related]
4. Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis.
Le TT; Karmouty-Quintana H; Melicoff E; Le TT; Weng T; Chen NY; Pedroza M; Zhou Y; Davies J; Philip K; Molina J; Luo F; George AT; Garcia-Morales LJ; Bunge RR; Bruckner BA; Loebe M; Seethamraju H; Agarwal SK; Blackburn MR
J Immunol; 2014 Oct; 193(7):3755-68. PubMed ID: 25172494
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial fission enhances IL-6-induced metastatic potential in ovarian cancer via ERK1/2 activation.
Lee J; Han Y; Kim S; Jo H; Wang W; Cho U; Kim SI; Kim B; Song YS
Cancer Sci; 2024 May; 115(5):1536-1550. PubMed ID: 38433313
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.
Mochizuki D; Adams A; Warner KA; Zhang Z; Pearson AT; Misawa K; McLean SA; Wolf GT; Nör JE
Oncotarget; 2015 Sep; 6(26):22822-35. PubMed ID: 26287605
[TBL] [Abstract][Full Text] [Related]
7. On the role of bacterial metalloproteases in COVID-19 associated cytokine storm.
Földvári-Nagy L; Schnabel T; Dörnyei G; Korcsmáros T; Lenti K
Cell Commun Signal; 2021 Jan; 19(1):7. PubMed ID: 33441142
[TBL] [Abstract][Full Text] [Related]
8. Overlapping and distinct biological effects of IL-6 classic and trans-signaling in vascular endothelial cells.
Montgomery A; Tam F; Gursche C; Cheneval C; Besler K; Enns W; Manku S; Rey K; Hanson PJ; Rose-John S; McManus BM; Choy JC
Am J Physiol Cell Physiol; 2021 Apr; 320(4):C554-C565. PubMed ID: 33471622
[TBL] [Abstract][Full Text] [Related]
9. Experiment-based computational model predicts that IL-6 classic and trans-signaling exhibit similar potency in inducing downstream signaling in endothelial cells.
Song M; Wang Y; Annex BH; Popel AS
NPJ Syst Biol Appl; 2023 Sep; 9(1):45. PubMed ID: 37735165
[TBL] [Abstract][Full Text] [Related]
10. Blockade of interleukin-6 trans-signaling prevents mitochondrial dysfunction and cellular senescence in retinal endothelial cells.
Hoffman JM; Robinson R; Greenway G; Glass J; Budkin S; Sharma S
Exp Eye Res; 2023 Dec; 237():109721. PubMed ID: 37956941
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
Leung CS; Yeung TL; Yip KP; Wong KK; Ho SY; Mangala LS; Sood AK; Lopez-Berestein G; Sheng J; Wong ST; Birrer MJ; Mok SC
J Clin Invest; 2018 Feb; 128(2):589-606. PubMed ID: 29251630
[TBL] [Abstract][Full Text] [Related]
12. Small protein blockers of human IL-6 receptor alpha inhibit proliferation and migration of cancer cells.
Groza Y; Lacina L; Kuchař M; Rašková Kafková L; Zachová K; Janoušková O; Osička R; Černý J; Petroková H; Mierzwicka JM; Panova N; Kosztyu P; Sloupenská K; Malý J; Škarda J; Raška M; Smetana K; Malý P
Cell Commun Signal; 2024 May; 22(1):261. PubMed ID: 38715108
[TBL] [Abstract][Full Text] [Related]
13. Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration.
Jayatilaka H; Tyle P; Chen JJ; Kwak M; Ju J; Kim HJ; Lee JSH; Wu PH; Gilkes DM; Fan R; Wirtz D
Nat Commun; 2017 May; 8():15584. PubMed ID: 28548090
[TBL] [Abstract][Full Text] [Related]
14. PRSS21/testisin inhibits ovarian tumor metastasis and antagonizes proangiogenic angiopoietins ANG2 and ANGPTL4.
Conway GD; Buzza MS; Martin EW; Duru N; Johnson TA; Peroutka RJ; Pawar NR; Antalis TM
J Mol Med (Berl); 2019 May; 97(5):691-709. PubMed ID: 30911775
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-27 Gene Delivery Targeting IL-6Rα-Expressing Cells as a Stress Response Therapy.
Figueiredo Neto M; Liu S; Salameh JW; Yokota H; Figueiredo ML
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046108
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.
Zhang Y; Yan W; Collins MA; Bednar F; Rakshit S; Zetter BR; Stanger BZ; Chung I; Rhim AD; di Magliano MP
Cancer Res; 2013 Oct; 73(20):6359-74. PubMed ID: 24097820
[TBL] [Abstract][Full Text] [Related]
17. The complex role of IL-10 in malignant ascites: a review.
Huang Y; Zou K; Jiang H; Li Z
Cancer Immunol Immunother; 2024 Jan; 73(2):32. PubMed ID: 38279997
[TBL] [Abstract][Full Text] [Related]
18. Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.
Dadgar N; Sherry C; Zimmerman J; Park H; Lewis C; Donnenberg A; Zaidi AH; Fan Y; Xiao K; Bartlett D; Donnenberg V; Wagner PL
J Transl Med; 2024 Apr; 22(1):402. PubMed ID: 38689325
[TBL] [Abstract][Full Text] [Related]
19. Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment.
Monavarian M; Elhaw AT; Tang PW; Javed Z; Shonibare Z; Scalise CB; Arend R; Jolly MK; Sewell-Loftin MK; Hempel N; Mythreye K
Semin Cancer Biol; 2022 Nov; 86(Pt 2):709-719. PubMed ID: 35259492
[TBL] [Abstract][Full Text] [Related]
20. Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFβ-ERK signaling.
Szeőcs D; Vida B; Petővári G; Póliska S; Janka E; Sipos A; Uray K; Sebestyén A; Krasznai Z; Bai P
Geroscience; 2024 Jan; ():. PubMed ID: 38196068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
